Form 4 Tracker
Rapport Therapeutics, Inc.
RAPP

40 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 16, 2025Jun 16 8:24 PMDAVID BREDT
Proposed Sale
34,000$11.19$380.5K—

View →

Mar 14, 2025Mar 14 8:20 PMDAVID BREDT
Proposed Sale
25,500$10.02$255.5K—

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 10, 2026Jun 10 9:57 PMJohn MaraganoreDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:52 PMRobert J PerezDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:46 PMSteven M PaulDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:28 PMPaul M SilvaDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:26 PMJames HealyDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:25 PMReid M HuberDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:24 PMWendy B. YoungDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:23 PMRamiro SanchezDirector
Grant/Award
15,200$35.2115,200(D)

View →

Feb 19, 2026Feb 20 12:05 AMDavid BredtChief Scientific Officer
Option Exercise
6,000$1.8088,080(D)

View →

Feb 2, 2026Feb 4 9:15 PMJeffrey SevignyChief Medical Officer
Grant/Award
130,000$27.75130,000(D)

View →

Feb 2, 2026Feb 4 9:14 PMAbraham CeesayDirector, Chief Executive Officer
Grant/Award
428,000$27.75428,000(D)

View →

Feb 2, 2026Feb 4 9:12 PMTroy A. IgnelziChief Financial Officer
Grant/Award
148,000$27.75148,000(D)

View →

Feb 2, 2026Feb 4 9:11 PMKrishnaswamy YeleswaramChief Development Officer
Grant/Award
120,000$27.75120,000(D)

View →

Feb 2, 2026Feb 4 9:09 PMDavid BredtChief Scientific Officer
Grant/Award
103,000$27.75103,000(D)

View →

Feb 2, 2026Feb 4 9:02 PMCheryl GaultChief Operating Officer
Grant/Award
132,000$27.75132,000(D)

View →